SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as the community discusses recent news and potential impacts from political decisions. Community members are focused on trade negotiations and tariff implications, as well as commentary around political figures and events. Broader discussions include market dynamics and potential financial strategies related to the stock.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as investors discuss its AI-powered biometric platform being deployed at Chicago O'Hare International Airport, sparking speculation about further airport security contracts and a potential TSA deal. The community is also focused on the company's large short interest and upcoming earnings, with some anticipating a squeeze. Bullish sentiment is fueled by the company's advancements in AI and its potential for significant growth within the national security sector.

$BALLIN is the perfect meme for everyone showing up every single day.  To be BALLIN, you gotta B-All-In.  The meaning to B All In doesn't only apply to the funds you invest.  It's about dedication.   The countless hours of research.   The endless raiding and working for your bags.  Not knowing how to quit while everyone is telling you you're wrong.  It's about believing in something.  Keep $BALLIN

B All In

The crypto asset $BALLIN is gaining attention, particularly within the Phantom Wallet community, with many highlighting its potential for significant gains. Community members are encouraged to buy and hold, emphasizing the opportunity for early entry and substantial profits. The focus is on strong upward momentum and the potential for a breakout.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies ($LUMN) is trending amid discussions about its role in AI infrastructure, particularly following a $200M deal with Palantir ($PLTR) to boost enterprise AI. Community members highlight Lumen's fiber optic network and partnerships with hyperscalers as key assets for AI data connectivity. Some are speculating on future earnings and potential government stakes in the company.

Mkango Resources Ltd.

Mkango Resources is trending amid discussions about rare earth elements and critical mineral demand. Community members are pointing to supply chain developments and broader interest in the sector as potential catalysts. Some traders are attributing recent price action to warrant exercises while others see it as a temporary cooling off period before another potential move.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending due to a sharp rebound after a significant decline, with community members debating whether the bottom has been reached and discussing potential catalysts like earnings and partnerships. The stock's connection to the AI infrastructure boom and recent news regarding accelerated power hookups for data centers are also fueling interest. Bullish investors are highlighting the company's long-term potential and the increasing demand for AI infrastructure.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is experiencing increased volatility, with community members actively discussing potential breakouts and resistance levels. Recent market activity and whale movements are sparking conversations about whether ETH can sustain its gains. Broader narratives around tokenization and potential ETF staking approvals are also influencing sentiment, adding to the current price swings.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending due to upcoming presentations at the Society for Immunotherapy of Cancer (SITC) annual meeting in November, where the company will share insights from its enLIGHTEN Discovery Platform and additional data from the CAN-2409 program. The community is also discussing the company's prioritization of prostate cancer and NSCLC, as well as potential partnerships for its pancreatic cancer treatment. Bullish investors are optimistic about the long-term potential, citing the large market opportunities and the company's experienced leadership team.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is trending due to recent earnings, mixed reactions to the CEO's conference call, and fluctuating gold prices, leading to debate on its short-term performance. The community is discussing whether NEM's stock drop is a buying opportunity or a sign of deeper issues, with some citing its strong fundamentals and others pointing to concerns about cash flow and CEO communication. Despite mixed sentiment, Newmont's long-term outlook remains positive, driven by solid earnings growth expectations and a potentially undervalued stock price in the precious metals mining sector.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as the community discusses its strong pharmaceutical pipeline and potential acquisitions, particularly after positive trial results and an increased focus on neuroscience. Bullish sentiment is fueled by rising sales of Skyrizi and Rinvoq, offsetting Humira's decline, alongside speculation about potential M&A activity in the sector. The community is closely watching upcoming earnings and price target adjustments by analysts.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?

KRYS gains momentum with Vyjuvek's expanded FDA label and global approvals, while advancing a pipeline led by oncology candidate KB707.

Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock?

Tango Therapeutics (TNGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update

KRYS shares jump after the FDA expands Vyjuvek's label to include DEB patients from birth, with added at-home use flexibility.

Krystal Biotech (KRYS) Up 8.5% Since Last Earnings Report: Can It Continue?

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

KRYS Q2 Earnings and Sales Top Estimates, Stock Down on Q3 Outlook

Krystal Biotech tops Q2 estimates with strong Vyjuvek sales, but shares fall 14% on weak Q3 revenue guidance.

Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates

Krystal Biotech (KRYS) delivered earnings and revenue surprises of +19.44% and +6.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tango Therapeutics (TNGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth

Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KRYS Begins Dosing With Gene Therapy in Rare Eye Disease, Stock Up

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

3 Promising Genomics Stocks to Keep an Eye On in 2025 

Investors interested in the Genomics and Synthetic Biology theme should keep an eye on MGTX, BEAM and KRYS. 

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Current Price	$186.45
Prev Close	$186.42
Open	$186.26
Dividend Yield	0.00%
50-Day Moving Average	$164.33
Beta	0.95
Avg. Volume	363,193.43
PE Ratio	37.93

52-Week High	$207.84
52-Week Low	$122.80
Market Capitalization	$5.4B
EPS (Annual)	$3.00
Price to Book	5.18
Revenue Per Employee	$1.06M
Enterprise Value/EBITDA	N/A

KRYS
Krystal Biotech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KRYS News

KRYSKrystal Biotech Inc